Invests in
Locations:
Min Investment:
$1,000,000.00Max Investment:
$75,000,000.00Target Investment:
$4,000,000.00
Education
- DU
- Uo
Lists including Jonathan
Investments
Aspen Neuroscience
Seed
Total Funding: $230M
AcureX Therapeutics
Grant
Total Funding:
NeuroPace
Series Unknown
Total Funding: $190M
Prevail Therapeutics
Series A
Total Funding: $130M
resTORbio
Series A
Total Funding: $40M
Audentes Therapeutics
Series A
Total Funding: $140M
Glaukos
Series D
Total Funding: $95M
Relypsa
Series B
Total Funding: $290M
Cerapedics
Series Unknown
Total Funding: $62M
Roka Bioscience
Series C
Total Funding: $68M
SuperDimension
Series B
Total Funding: $65M
Enobia Pharma
Series B
Total Funding: $88M
Avanir Pharmaceuticals
Post Ipo Equity
Total Funding: $16M
Adiana
Series D
Total Funding: $23M
Work Experience
President and Co-Founder
2017
Founded in 2017, The Silverstein Foundation for Parkinson's with GBA actively pursues and invests in cutting edge research with the goal of discovering new therapies for the treatment of Parkinson's Disease in glucocerebrosidase (GBA) mutation carriers.
1999
Former Co-Head of Private Equity and Managing Partner / Currently an Executive Partner
1999